サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1625455

バイオテクノロジー市場、規模、シェア、動向、産業分析レポート：技術、用途、地域別 - 市場予測、2025年～2034年

Biotechnology Market Size, Share, Trends, Industry Analysis Report: By Technology, Application and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 125 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バイオテクノロジー市場、規模、シェア、動向、産業分析レポート：技術、用途、地域別 - 市場予測、2025年～2034年
出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの新しい調査によると、バイオテクノロジー市場規模は2034年までに5兆8,500億米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

慢性疾患の罹患率の増加と革新的な治療のイントロダクションが、バイオテクノロジー市場の収益成長を促進しています。バイオテクノロジーは多くの疾患の治療に非常に有益であることが証明されており、製薬業界は、発酵ブロスでの抗生物質産生微生物の培養から精製抗生物質製品の入手に至るまで、バイオテクノロジー技術を採用しています。さらに、現代のバイオテクノロジーを応用することで、数多くの疾患特異的な先端治療アプローチの有効性を高める可能性があります。バイオテクノロジーはヘルスケアシステムにおいて重要な役割を果たしており、様々な病気の治療に使われる数多くの医薬品やワクチンの生産に大きく貢献しています。さらに、ヘルスケアシステムに不可欠なその他のさまざまな医療処置にも、バイオテクノロジーの利用が関わっています。

有機食品への要望の高まりは、農業分野におけるバイオテクノロジーの不可欠性を強調し、市場の収益拡大に貢献しています。バイオテクノロジーは、生産高をより費用対効果が高く管理しやすくする技術を農家に提供します。例えば、特定のバイオ作物は特定の除草剤に耐えられるように遺伝子組み換えが可能で、雑草防除の効率と効果を高める。さらにバイオテクノロジーは、特定の植物病害や害虫に耐性を持つ作物の育種を支援し、その結果、合成農薬の使用を最小限に抑え、害虫駆除を強化することが可能になります。作物生産におけるこうした選択肢は、生産コストを削減するだけでなく、各国が食糧需要を満たす助けにもなります。

バイオテクノロジー市場レポートハイライト

遺伝子研究における政府資金の増加により、DNAシークエンシング分野が2024年に最大シェアを占める

健康分野は、世界の疾病負担の増加により、バイオテクノロジー市場で大きな成長が見込まれます。

アジア太平洋地域は、投資の増加、ヘルスケアインフラの強化、有利な政府イニシアティブ、主要市場企業による戦略的拡大努力により、世界市場で大きな成長を遂げています。

2024年、北米のバイオテクノロジー市場は、主要企業の存在、広範な研究開発活動、多額のヘルスケア支出により、最大の収益を記録しました。

世界の主要市場企業は、Abbott Laboratories; Amgen Inc.; AstraZeneca; Biogen; Bristol-Myers Squibb; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; Johnson & Johnson Services, Inc.; Lonza; Merck KGaA; Novartis AG; Novo Nordisk A/S; Pfizer, Inc and Sanofi.です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のバイオテクノロジー市場の洞察

  • 市場スナップショット
  • バイオテクノロジー市場力学
    • 促進要因と機会
      • 慢性疾患の増加
      • 農業における需要の高まり
    • 抑制要因と課題
      • 熟練労働力の不足
  • PESTEL分析
  • バイオテクノロジー市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のバイオテクノロジー市場：技術別

  • 主な調査結果
  • イントロダクション
  • 発酵
  • 組織工学と再生
  • クロマトグラフィー
  • PCR技術
  • ナノバイオテクノロジー
  • DNA配列解析
  • その他

第6章 世界のバイオテクノロジー市場： 用途別

  • 主な調査結果
  • イントロダクション
  • バイオインフォマティクス
  • 食品と農業
  • 健康
  • 産業処理
  • 天然資源と環境
  • その他

第7章 世界のバイオテクノロジー市場：地域別

  • 主な調査結果
  • イントロダクション
    • バイオテクノロジー市場評価：地域、2020-2034年
  • 北米
    • 北米：技術別、2020-2034年
    • 北米：用途別、2020-2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：技術別、2020-2034年
    • 欧州：用途別、2020-2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：技術別、2020-2034年
    • アジア太平洋：用途別、2020-2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：技術別、2020-2034年
    • 中東・アフリカ：用途別、2020-2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：技術別、2020-2034年
    • ラテンアメリカ：用途別、2020-2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Abbott Laboratories
  • Amgen Inc.
  • AstraZeneca
  • Biogen
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Johnson & Johnson Services, Inc.
  • Lonza
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc
  • Sanofi
図表

List of Tables:

Table 1 Global Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 2 Global Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 3 North America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 4 North America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 5 U.S.: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 6 U.S.: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 7 Canada: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 8 Canada: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 9 Europe: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 10 Europe: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 11 UK: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 12 UK: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 13 France: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 14 France: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 15 Germany: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 16 Germany: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 17 Italy: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 18 Italy: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 19 Spain: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 20 Spain: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 21 Netherlands: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 22 Netherlands: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 23 Russia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 24 Russia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 25 Rest of Europe: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 26 Rest of Europe: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 27 Asia Pacific: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 28 Asia Pacific: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 29 China: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 30 China: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 31 India: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 32 India: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 33 Malaysia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 34 Malaysia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 35 Japan: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 36 Japan: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 37 Indonesia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 38 Indonesia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 39 South Korea: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 40 South Korea: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 41 Australia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 42 Australia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 43 Rest of Asia Pacific: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 44 Rest of Asia Pacific: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 45 Middle East & Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 46 Middle East & Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 47 Saudi Arabia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 48 Saudi Arabia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 49 UAE: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 50 UAE: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 51 Israel: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 52 Israel: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 53 South Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 54 South Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 55 Rest of Middle East & Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 56 Rest of Middle East & Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 57 Latin America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 58 Latin America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 59 Mexico: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 60 Mexico: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 61 Brazil: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 62 Brazil: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 63 Argentina: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 64 Argentina: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

Table 65 Rest of Latin America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)

Table 66 Rest of Latin America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

List of Figures:

Figure 1. Global Biotechnology Market, 2020-2034 (USD Trillion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Technology

Figure 7. Global Biotechnology Market, by Technology, 2024 & 2034 (USD Trillion)

Figure 8. Market by Application

Figure 9. Global Biotechnology Market, by Application, 2024 & 2034 (USD Trillion)

目次
Product Code: PM1011

The biotechnology market size is expected to reach USD 5.85 trillion by 2034, according to a new study by Polaris Market Research. The report "Biotechnology Market Size, Share, Trends, Industry Analysis Report: By Technology, Application (Bioinformatics, Food & Agriculture, Health, Industrial Processing, Natural Resources and Environment, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increase in the incidence of chronic diseases and the introduction of innovative treatments are driving the growth of biotechnology market revenue. Biotechnology proves highly beneficial in the treatment of many diseases, with the pharmaceutical industry employing biotechnological techniques from cultivating antibiotic-producing microorganisms in fermentation broth to obtaining a purified antibiotic product. Furthermore, the application of modern biotechnology has the potential to enhance the effectiveness of numerous disease-specific advanced therapeutic approaches. Biotechnology plays a crucial role in the healthcare system, contributing significantly to the production of numerous drugs and vaccines used in the treatment of various diseases. Additionally, various other medical procedures integral to the healthcare system involve the utilization of biotechnology.

The increasing desire for organic food products underscores the indispensability of biotechnology in the agricultural sector, contributing to the market's revenue growth. Biotechnology provides farmers with technologies that can render output more cost-effective and manageable. For instance, certain biotech crops can be genetically modified to withstand specific herbicides, enhancing the efficiency and effectiveness of weed control. Additionally, biotechnology supports breeding crops to be resistant to particular plant diseases and insect pests, due to which it becomes possible to minimize the use of synthetic pesticides and enhance pest control. These options in crop production not only reduce production costs but also aid countries in meeting the demand for food.

Biotechnology Market Report Highlights

The DNA sequencing segment accounted for largest share in 2024 due to increase in government fundings in the genetic research

The health segment is market is expected to experience significant growth in the biotechnology market due to the increasing burden of diseases worldwide.

The Asia Pacific region is experiencing significant growth in the global market due to increasing investments, enhancements in healthcare infrastructure, favorable government initiatives, and strategic expansion efforts by key market players

In 2024, North America biotechnology market recorded largest revenue due to presence of key players, extensive research and development activities, and substantial healthcare expenditure.

The global key market players are Abbott Laboratories; Amgen Inc.; AstraZeneca; Biogen; Bristol-Myers Squibb; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; Johnson & Johnson Services, Inc.; Lonza; Merck KGaA; Novartis AG; Novo Nordisk A/S; Pfizer, Inc and Sanofi.

Polaris market research has segmented the biotechnology market report based on technology, application and region:

By Technology (Revenue - USD Trillion, 2020-2034)

§ Fermentation

§ Tissue Engineering and Regeneration

§ Chromatography

§ PCR Technology

§ Nanobiotechnology

§ Cell-based Assays

§ DNA Sequencing

§ Others

By Application (Revenue - USD Trillion, 2020-2034)

§ Bioinformatics

§ Food & Agriculture

§ Health

§ Industrial Processing

§ Natural Resources & Environment

§ Others

By Regional Outlook (Revenue - USD Trillion, 2020-2034)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biotechnology Market Insights

  • 4.1. Biotechnology Market - Market Snapshot
  • 4.2. Biotechnology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Chronic Illnesses
      • 4.2.1.2. Rising Demand in Agriculture
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Skilled Workforce
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Biotechnology Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biotechnology Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
  • 5.3. Fermentation
    • 5.3.1. Global Biotechnology Market, by Fermentation, by Region, 2020-2034 (USD Trillion)
  • 5.4. Tissue Engineering and Regeneration
    • 5.4.1. Global Biotechnology Market, by Tissue Engineering and Regeneration, by Region, 2020-2034 (USD Trillion)
  • 5.5. Chromatography
    • 5.5.1. Global Biotechnology Market, by Chromatography, by Region, 2020-2034 (USD Trillion)
  • 5.6. PCR Technology
    • 5.6.1. Global Biotechnology Market, by PCR Technology, by Region, 2020-2034 (USD Trillion)
  • 5.7. Nanobiotechnology
    • 5.7.1. Global Biotechnology Market, by Nanobiotechnology, by Region, 2020-2034 (USD Trillion)
  • 5.8. DNA Sequencing
    • 5.8.1. Global Biotechnology Market, by DNA Sequencing, by Region, 2020-2034 (USD Trillion)
  • 5.9. Others
    • 5.9.1. Global Biotechnology Market, by Others, by Region, 2020-2034 (USD Trillion)

6. Global Biotechnology Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 6.3. Bioinformatics
    • 6.3.1. Global Biotechnology Market, by Bioinformatics, by Region, 2020-2034 (USD Trillion)
  • 6.4. Food & Agriculture
    • 6.4.1. Global Biotechnology Market, by Food & Agriculture, by Region, 2020-2034 (USD Trillion)
  • 6.5. Health
    • 6.5.1. Global Biotechnology Market, by Health, by Region, 2020-2034 (USD Trillion)
  • 6.6. Industrial Processing
    • 6.6.1. Global Biotechnology Market, by Industrial Processing, by Region, 2020-2034 (USD Trillion)
  • 6.7. Natural Resources & Environment
    • 6.7.1. Global Biotechnology Market, by Natural Resources & Environment, by Region, 2020-2034 (USD Trillion)
  • 6.8. Others
    • 6.8.1. Global Biotechnology Market, by Others, by Region, 2020-2034 (USD Trillion)

7. Global Biotechnology Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Biotechnology Market Assessment, By Geography, 2020-2034 (USD Trillion)
  • 7.3. Biotechnology Market - North America
    • 7.3.1. North America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.3.2. North America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.3.3. Biotechnology Market - U.S.
      • 7.3.3.1. U.S.: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.3.3.2. U.S.: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.3.4. Biotechnology Market - Canada
      • 7.3.4.1. Canada: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.3.4.2. Canada: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4. Biotechnology Market - Europe
    • 7.4.1. Europe: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.2. Europe: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.3. Biotechnology Market - UK
      • 7.4.3.1. UK: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.3.2. UK: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.4. Biotechnology Market - France
      • 7.4.4.1. France: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.4.2. France: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.5. Biotechnology Market - Germany
      • 7.4.5.1. Germany: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.5.2. Germany: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.6. Biotechnology Market - Italy
      • 7.4.6.1. Italy: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.6.2. Italy: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.7. Biotechnology Market - Spain
      • 7.4.7.1. Spain: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.7.2. Spain: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.8. Biotechnology Market - Netherlands
      • 7.4.8.1. Netherlands: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.8.2. Netherlands: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.9. Biotechnology Market - Russia
      • 7.4.9.1. Russia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.9.2. Russia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.4.10. Biotechnology Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.4.10.2. Rest of Europe: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5. Biotechnology Market - Asia Pacific
    • 7.5.1. Asia Pacific: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.2. Asia Pacific: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.3. Biotechnology Market - China
      • 7.5.3.1. China: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.3.2. China: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.4. Biotechnology Market - India
      • 7.5.4.1. India: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.4.2. India: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.5. Biotechnology Market - Malaysia
      • 7.5.5.1. Malaysia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.5.2. Malaysia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.6. Biotechnology Market - Japan
      • 7.5.6.1. Japan: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.6.2. Japan: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.7. Biotechnology Market - Indonesia
      • 7.5.7.1. Indonesia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.7.2. Indonesia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.8. Biotechnology Market - South Korea
      • 7.5.8.1. South Korea: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.8.2. South Korea: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.9. Biotechnology Market - Australia
      • 7.5.9.1. Australia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.9.2. Australia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.5.10. Biotechnology Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.5.10.2. Rest of Asia Pacific: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.6. Biotechnology Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.6.2. Middle East & Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.6.3. Biotechnology Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.6.3.2. Saudi Arabia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.6.4. Biotechnology Market - UAE
      • 7.6.4.1. UAE: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.6.4.2. UAE: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.6.5. Biotechnology Market - Israel
      • 7.6.5.1. Israel: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.6.5.2. Israel: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.6.6. Biotechnology Market - South Africa
      • 7.6.6.1. South Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.6.6.2. South Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.6.7. Biotechnology Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.6.7.2. Rest of Middle East & Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.7. Biotechnology Market - Latin America
    • 7.7.1. Latin America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.7.2. Latin America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.7.3. Biotechnology Market - Mexico
      • 7.7.3.1. Mexico: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.7.3.2. Mexico: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.7.4. Biotechnology Market - Brazil
      • 7.7.4.1. Brazil: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.7.4.2. Brazil: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.7.5. Biotechnology Market - Argentina
      • 7.7.5.1. Argentina: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.7.5.2. Argentina: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
    • 7.7.6. Biotechnology Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
      • 7.7.6.2. Rest of Latin America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Amgen Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. AstraZeneca
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Biogen
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Bristol-Myers Squibb
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. F. Hoffmann-La Roche Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Gilead Sciences, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Johnson & Johnson Services, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Lonza
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Merck KGaA
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Novartis AG
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Novo Nordisk A/S
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Pfizer, Inc
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Sanofi
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development